Endovascular and microsurgical management of blister aneurysms: a multi-centre review.
Joseph ReidyKenneth FaulderKeryn DavidsonTimothy HarringtonBrendan SteinfortNazih AssaadMark DexterAlice MaPublished in: Neurosurgical review (2023)
Blister aneurysms (BA) are high-risk cerebrovascular lesions accounting for 1% of intracranial aneurysms. The defective vessel wall and broad-based neck make this clinical entity difficult to treat, with high rates of re-rupture and mortality in patients presenting with acute subarachnoid haemorrhage. Blister aneurysms pose substantial challenges for both endovascular and microsurgical management. The objective of this study is to evaluate endovascular and microsurgical outcomes in intracranial blister aneurysm management across two tertiary hospitals. A review of two tertiary hospitals with a systematic imaging database search for term of "blister" in modalities from January 2010 to October 2022 was conducted. Operation reports were screened for the 5-year period since cerebral angiogram reports transitioned to surgical database. Identified reports were screened and reviewed for confirmed diagnosis by consultant neuroradiologist. A total of 21 cases of blister aneurysms managed at respective facilities were included. Sixteen cases (76%) were managed endovascularly. Four cases (19%) were managed surgically-2 with primary clipping, and 2 wrap and clipping. One case was managed conservatively (5%). Clinical outcomes were discharge disposition, aneurysm exclusion and post-operative complications. BAs have challenging considerations with high mortality and morbidity. Endovascular treatment offers a less invasive modality with lower rates of intraoperative rupture and morbidity. Mortality rates and patients discharged home were comparable. Commencement of dual anti-platelet therapy was safe in patients with flow diversion stents despite sub-arachnoid blood volume. Management of blister aneurysms is complex. Endovascular treatment shows promise for acute management but careful collaborative consideration of antithrombotic regime and requirement for further surgery should be considered.
Keyphrases
- endovascular treatment
- healthcare
- risk factors
- aortic dissection
- minimally invasive
- adverse drug
- liver failure
- coronary artery
- intensive care unit
- ejection fraction
- preterm infants
- cardiovascular disease
- patients undergoing
- mesenchymal stem cells
- deep learning
- coronary artery bypass
- big data
- patient reported
- adipose tissue
- prognostic factors
- acute respiratory distress syndrome
- respiratory failure
- robot assisted
- metabolic syndrome
- optic nerve
- middle cerebral artery